Surgical resection of Masaoka stage III thymic epithelial tumours with great vessels involvement: a retrospective multicentric analysis from the European Society of Thoracic Surgeons thymic database

Author:

Mendogni Paolo1ORCID,Toker Alper2ORCID,Moser Bernhard3ORCID,Trancho Florentino Hernando4ORCID,Aigner Clemens5ORCID,Bravio Ivan Gomes6ORCID,Novoa Nuria Maria7ORCID,Molins Laureano8ORCID,Costardi Lorena9,Voltolini Luca10ORCID,Ardò Nicoletta Pia11ORCID,Verdonck Bram12,Ampollini Luca13ORCID,Zisis Charlambos14,Barmin Vitaly15ORCID,Enyedi Attila16,Ruffini Enrico9ORCID,Van Raemdonck Dirk17ORCID,Thomas Pascal-Alexandre18,Weder Walter19,Rocco Gaetano20ORCID,Brunelli Alessandro21ORCID,Detterbeck Frank C22ORCID,Venuta Federico23ORCID,Falcoz Pierre-Emmanuel24ORCID,Tosi Davide1ORCID,Bonitta Gianluca1,Nosotti Mario125ORCID,Ozkan Berker,Cımenoglu Berk,Thanner Jürgen,Olivero Carlos Fraile,Alvarado Rodriguez,Boada Marc,Bongiolatti Stefano,Sollitto Francesco,Van Schil Paul,Bocchialini Giovanni,Brioude Geoffrey,

Affiliation:

1. Thoracic Surgery and Lung Transplant Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico , Milan, Italy

2. Istanbul University, Istanbul Medical School Department of Thoracic Surgery , Istanbul, Turkey

3. Department of Thoracic Surgery, Medical University of Vienna , Vienna, Austria

4. Hospital Clínico San Carlos, Universidad Complutense Madrid , Madrid, Spain

5. Department of Thoracic Surgery, Ruhrlandklinik—West German Lung Center, University Hospital Essen , Essen, Germany

6. Department of Thoracic Surgery, Francisco Gentil Portuguese Institute of Oncology CUF Infante Santo Hospital , Lisboa, Portugal

7. Thoracic Surgery Service, Salamanca University Hospital and School of Medicine , Salamanca, Spain

8. Department of Thoracic Surgery, Hospital Clinic, Barcelona University , Barcelona, Spain

9. Department of Thoracic Surgery, University of Torino , Torino, Italy

10. Department of Thoracic Surgery, Careggi University Hospital , Florence, Italy

11. Thoracic Surgery Unit, University Hospital—“Policlinico Riuniti” , Foggia, Italy

12. Department of Thoracic and Vascular Surgery, Antwerp University Hospital and Antwerp University , Antwerp, Belgium

13. Thoracic Surgery, Department of Medicine and Surgery, University Hospital of Parma , Parma, Italy

14. Department of Thoracic Surgery, Athens Evangelismos Hospital , Athens, Greece

15. Department of Thoracic Surgery, P.A. Hertsen Moscow Oncology Research Center , Moskow, Russia

16. Division of Thoracic Surgery, University of Debrecen , Debrecen, Hungary

17. Department of Thoracic Surgery, University Hospitals Leuven , Leuven, Belgium

18. Department of Thoracic Surgery, North Hospital, Aix-Marseille University & Assistance Publique-Hôpitaux de Marseille , Marseille, France

19. Division of Thoracic Surgery, University Hospital Zurich , Zurich, Switzerland

20. Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center , New York, NY, USA

21. Department of Thoracic Surgery, St. James’s University Hospital , Leeds, UK

22. Section of Thoracic Surgery, Department of Surgery, Yale Thoracic Oncology Program, Yale University School of Medicine , New Haven, CT, USA

23. Division of Thoracic Surgery and Lung Transplant, Sapienza University of Rome and AOU Policlinico Umberto I , Roma, Italy

24. Department of Thoracic Surgery, Strasbourg University Hospital , Strasbourg, France

25. Department of Pathophysiology and Transplantation, University of Milan , Milan, Italy

Abstract

Abstract OBJECTIVES The aim of this study was to analyse the outcomes of an international cohort of patients affected by Masaoka stage III thymic epithelial tumours with vascular involvement and treated by surgery. METHODS Study design was the observational multicentre retrospective cohort study. Data were extracted from the European Society of Thoracic Surgeons thymic database; additional variables were collected. Inclusion criteria were as follows: stage III (Masaoka–Koga) thymic epithelial tumours; surgery with radical intention; clinical or pathological great vessels involvement; and radiologically suspected or diagnosed intraoperatively. Outcome items were analysed. RESULTS Sixty-five patients submitted to surgery from 2001 to 2017 fulfilled inclusion criteria. Thymoma and thymic carcinoma patients did not differ for demographics and clinical characteristics. The majority of great vessel treated were superior vena cava or innominate veins (72.3%). Eleven patients (16.9%) had postoperative cardiopulmonary complications; vascular stenosis was observed in 3 patients (4.6%). The multivariable Cox analysis for disease-free survival showed an increased hazard of recurrence for thymic carcinoma (hazard ratio = 3.59; 95% confidence interval: 1.66–7.78, P = 0.001). The 1-, 3-, 5- and 10-year overall survival rates were 0.86, 0.84, 0.81, and 0.53, respectively. There was no significant difference in overall survival according to resection status or between thymoma and thimic carcinoma. The univariable Cox regression model did not show an increased hazard of death for myasthenic patients considering all resection status and for patients who received neoadjuvant therapy. CONCLUSIONS We observed that clinical outcomes of patients treated for stage III thymic epithelial tumours with vascular involvement are satisfactory suggesting to increase the confidence in dealing with these complex surgeries. Complete resection should be achieved, even though extensive vascular reconstructions are required.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3